Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ to treat patients with atrial fibrillation (AFib). Following the new ...
Abbott’s latest CE mark for its TactiFlex Duo system was based on a clinical trial conducted in the European Union, United ...
First In-Man Experience Exceeds Expectations, Cited as “Game Changer” for Below-the-Knee Procedures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Summa Therapeutics, LLC announced today that the first-in-man ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
SAN FRANCISCO—At the annual J.P. Morgan Healthcare Conference, Microbot Medical unveiled a new device that aims to let physicians conduct a catheter-based procedure from outside the operating room, ...
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Abbott (NYSE: ABT) announced today that it received CE mark for its TactiFlex Duo Ablation Catheter, Sensor-Enabled.
Central venous catheters (CVCs) help deliver medication, fluids, blood, or nutrition. They can also be useful for monitoring and performing certain tests and procedures. Placing CVCs or central lines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback